Sakar Healthcare Share Price

Sakar Healthcare Share Price

NSE: SAKAR
|
Pharmaceuticals
|
S Cap
₹ 990.00
+₹24.25 (2.51%)
1D
Last updated 02 Sep, 2026, 15:29 IST

Sakar Healthcare Share Price Today

As of 3 Sep 2026, Sakar Healthcare share price is ₹990.00. The stock opened at ₹993.00, compared to its previous close of ₹965.75. During today's trading session, Sakar Healthcare share price moved in the range of ₹975.50 to ₹1,024.00, with an average price of ₹999.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹321.05 and a high of ₹1,024.00. On the performance front, Sakar Healthcare share price has increased by 88.11% over the last six months and is up 192.61% on a year-on-year basis.


₹975.50
2.51% up today
₹1,024.00
1D LOW
1D HIGH

Sakar Healthcare Returns Calculator


Circuit
L
H
₹788.65
₹1,182.95
52-week
L
H
₹321.05
₹1,024.00

About Sakar Healthcare

Sakar Healthcare Share Price
ISIN
INE732S01012
Sector Market Cap
₹ 2,193.4 Cr

Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.

Sakar Healthcare Financial Highlights

  • Revenue: Sakar Healthcare reported revenue of ₹254.03 crore in FY26 vs ₹178.89 crore in FY25. It showed an increase of 42.00% on a yearly basis.
  • Operating Profit: Sakar Healthcare reported an operating profit of ₹39.76 crore in FY26 vs ₹21.53 crore in FY25. It showed an increase of 84.67% on a year-on-year basis.
  • Net Profit: Sakar Healthcare reported a net profit of ₹30.48 crore in FY26 vs ₹17.50 crore in FY25. It showed an increase of 74.17% on a yearly basis.

Sakar Healthcare Quarterly Result Highlights

  • Sakar Healthcare reported revenue of ₹74.51 crore in Jun 2026, compared with ₹71.27 crore in Mar 2026, representing an increase of 4.55% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported an operating profit of ₹14.58 crore in Jun 2026, compared with ₹18.06 crore in Mar 2026, representing a decrease of 19.27% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported a profit of ₹10.28 crore in Jun 2026, compared with ₹11.02 crore in Mar 2026, reflecting a decrease of 6.72% on a QoQ basis.
  • The earnings per share (EPS) of Sakar Healthcare stood at ₹7.97 during Jun 2026.
Know more
Promoters
52.52%
FII
12.14%
Other DII
11.37%
Retail and other
23.98%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 202513.31%
Dec 202513.05%
Mar 202612.94%
Jun 202612.14%
Mkt Cap Cr
2,193.40

P/E
60.78

P/B
6.76

ROE
9.40%

D/E
0.17

ROCE
12.54%

Div. Yield
0.00%

EPS(TTM)
13.70
Turnover
0.57

EV/EBITDA
27.44

Net Margin
12.11%

Op. Margin
28.28%

ROA
7.50%

Quick Ratio
0.64

Curr. Ratio
1.64
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sakar Healthcare outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Sakar Healthcare appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Sakar Healthcare revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

Sakar Healthcare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹177.58₹153.35₹133.36₹128.23
Other Income₹1.31₹3.18₹4.67₹2.17
Total Revenue₹178.90₹156.53₹138.03₹130.40
Total Expenses₹157.32₹140.63₹121.15₹111.39
Profit Before Tax₹21.53₹15.90₹16.88₹19.01
Tax₹4.03₹4.23₹4.12₹3.77
Profit After Tax₹17.50₹11.67₹12.76₹15.24
EPS - Basic₹7.97₹5.63₹6.75₹9.96
EPS - Diluted₹7.95₹5.63₹6.75₹9.96

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹119.78₹9.60
Change in WC-₹17.29-₹14.08₹101.03₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.47₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.47₹0.09

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹326.53₹317.05₹280.42₹217.74
Current Assets₹88.73₹71.61₹55.92₹50.02
Total Assets₹415.26₹388.66₹336.34₹267.76
Current Liabilities₹63.19₹59.06₹54.49₹46.78
Net Current Asset₹25.54₹12.55₹1.42₹3.25
Non-Current Liabilities₹66.60₹67.27₹108.50₹93.54
Equity Capital₹285.48₹262.33₹173.35₹127.45
Total Equity & Liabilities₹415.26₹388.66₹336.34₹267.76

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹251.74₹177.58₹153.35₹133.36
Other Income₹2.29₹1.31₹3.18₹4.67
Total Revenue₹254.02₹178.90₹156.53₹138.03
Total Expenses₹214.27₹157.32₹140.63₹121.15
Profit Before Tax₹39.76₹21.53₹15.90₹16.88
Tax₹9.27₹4.03₹4.23₹4.12
Profit After Tax₹30.48₹17.50₹11.67₹12.76
EPS - Basic₹13.70₹7.97₹5.64₹6.75
EPS - Diluted₹13.70₹7.95₹5.63₹6.75

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹5.57₹9.60
Change in WC-₹17.29-₹14.08-₹13.18₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.46₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.46₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹340.56₹326.54₹317.06₹280.43
Current Assets₹140.53₹88.80₹71.69₹55.99
Total Assets₹481.09₹415.35₹388.74₹336.42
Current Liabilities₹109.54₹63.19₹59.06₹54.49
Net Current Asset₹31.00₹25.62₹12.63₹1.50
Non-Current Liabilities₹47.02₹66.60₹67.27₹108.50
Equity Capital₹324.54₹285.56₹262.42₹173.43
Total Equity & Liabilities₹481.09₹415.35₹388.74₹336.42
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
64.11
Neutral

ATR (14)
48.86
Neutral

STOCH(9,6)
79.73
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
25
Bearish

UO(9)
51.83
Neutral

ROC(12)
9.35
Bullish

WillR(14)
-17.67
Bearish
Period
Simple value
Exponential vaue

5D
916.64
934.4

10D
906.62
916.82

20D
908.46
904.39

50D
874.88
867.67

100D
792.34
792.88
Volume trend — traded volume by day
2 Sep3L
1 Sep11L
31 Aug0L
28 Aug0L
27 Aug0L
Average3L
Compare against other stocks
Sakar Healthcare Share Price
Sakar Healthcare
Pharmaceuticals
Add Stock
Add Another

Sakar Healthcare Share Price FAQs